[HTML][HTML] Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management

M Waiz, SS Alvi, MS Khan - EXCLI journal, 2022 - ncbi.nlm.nih.gov
Atherosclerotic cardiovascular disease (ASCVD) stands amongst the leading causes of
mortality worldwide and has attracted the attention of world's leading pharmaceutical …

The molecular mechanisms of ginkgo (Ginkgo biloba) activity in signaling pathways: A comprehensive review

AM Zonouz, MG Rahbardar, H Hosseinzadeh - Phytomedicine, 2024 - Elsevier
Background One of the most unique plants that have ever grown on the planet is Ginkgo
biloba L., a member of the Ginkgoaceae family with no close living relatives. The existence …

Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes

T Hiyoshi, M Fujiwara, Z Yao - Journal of biomedical research, 2017 - pmc.ncbi.nlm.nih.gov
Postprandial glucose level is an independent risk factor for cardiovascular disease that
exerts effects greater than glucose levels at fasting state, whereas increase in serum …

Extracts of edible plants inhibit pancreatic lipase, cholesterol esterase and cholesterol micellization, and bind bile acids

S Adisakwattana, J Intrawangso, A Hemrid… - Food Technology and …, 2012 - hrcak.srce.hr
Sažetak The application of edible plants with more effective ability to inhibit fat digestion and
absorption has recently been explored for possible treatment of hyperlipidaemia. The aim of …

Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non …

Z Li, S Tian, Z Wu, X Xu, L Lei, Y Li, B Wang… - Journal of …, 2021 - Elsevier
Ethnopharmacological relevance Ginkgo biloba L. is a traditional Chinese medicine for
hyper lipaemia. Ginkgo flavonols and terpene lactones are responsible for the lipid-lowering …

Dietary Ginkgo biloba leaf extract alters immune-related gene expression and disease resistance to Aeromonas hydrophila in common carp Cyprinus carpio

L Bao, Y Chen, H Li, J Zhang, P Wu, KE Ye, H Ai… - Fish & shellfish …, 2019 - Elsevier
Ginkgo biloba leaf is widely used in traditional medicine in China. The present study aimed
to illustrate the effects of dietary Ginkgo biloba leaf extract (GBLE) on growth performance …

Beneficial effects of plant-derived natural products on non-alcoholic fatty liver disease

LE Simental-Mendía, CI Gamboa-Gómez… - … Properties of Plant …, 2021 - Springer
Non-alcoholic fatty liver disease is becoming in one of the most prevalent liver diseases that
leads to liver transplantation. This health problem is a multisystem disease with a complex …

An update on drug interactions with the herbal medicine Ginkgo biloba

M Jose Abad, L Miguel Bedoya… - Current drug …, 2010 - ingentaconnect.com
Medicinal plants are gaining in popularity due to the various advantages they offer, such as
fewer side-effects, better patient compliance, relatively low cost and high accessibility as …

IL-33 promotes IL-10 production in macrophages: a role for IL-33 in macrophage foam cell formation

HF Zhang, MX Wu, YQ Lin, SL Xie, TC Huang… - … & molecular medicine, 2017 - nature.com
We evaluated the role of IL-10-in IL-33-mediated cholesterol reduction in macrophage-
derived foam cells (MFCs) and the mechanism by which IL-33 upregulates IL-10. Serum IL …

Effects of Ginkgo biloba intake on cardiometabolic parameters in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis of clinical trials

R Tabrizi, P Nowrouzi‐Sohrabi, K Hessami… - Phytotherapy …, 2021 - Wiley Online Library
Ginkgo biloba (GKB) may have a beneficial effect on cardiometabolic parameters in type 2
diabetes mellitus (T2DM), but the data is inconsistent. Therefore, the current systematic …